Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer | Zendy

Carmit K. McMullen | Zendy; Maureen O’Keeffe Rosetti | Zendy; Sheila Weinmann | Zendy; Michael C. Leo | Zendy; Matthew E. Nielsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer

Author(s) -

Carmit K. McMullen,

Maureen O’Keeffe Rosetti,

Sheila Weinmann,

Michael C. Leo,

Matthew E. Nielsen

Publication year - 2019

Publication title -

the permanente journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.445

H-Index - 30

eISSN - 1552-5775

pISSN - 1552-5767

DOI - 10.7812/tpp/18.276

Subject(s) - medicine , bladder cancer , health care , population , documentation , risk assessment , gynecology , intensive care medicine , family medicine , cancer , computer security , environmental health , computer science , economics , programming language , economic growth

Among the approximately 53,000 patients newly diagnosed with early-stage (superficial) bladder cancer each year, there is substantial variability in the progression to muscle-invasive disease. Enhancing risk stratification and risk-stratified surveillance could minimize risks and harms to patients, as well as unnecessary costs to health systems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research